Drug Trial Radar · NCT06263959
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Last checked: Nov 20, 2026Latest source record: Mar 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
45
Planned (sponsor's estimate)
Start
Dec 26, 2023
Primary completion
Apr 1, 2025
Study completion May 1, 2025
Sponsor
- Lead sponsor
- Fujian Akeylink Biotechnology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 35 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized, double-blind, placebo-controlled Phase IIa clinical study to evaluate the safety and efficacy of GST-HG131 tablets in patients with chronic hepatitis B
Conditions
- Chronic Hepatitis B
Interventions
GST-HG131Drug
GST-HG131 will be administered.
Placebo to match GST-HG131Drug
Placebo to match GST-HG131 will be administered.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in HBsAg levelsTime frame: Baseline and up to 56 days(Cohort1 and 2) or 16 weeks(Cohort3)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Fifth Medical Center of Chinese PLA General Hospital
Beijing, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.